Amneal Pharmaceuticals Inc Class A (AMRX)

CapEx to Revenue

5.73%

Quarterly · Period ending:

AMRX logo

AMRX CapEx to Revenue

Latest reported5.73%
AMRX Quarterly CapEx/Revenue (10.45% → 5.73%)
High-resolution chart · PNG

AMRX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amneal Pharmaceuticals Inc Class A CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
5.7262%
1.9183%
5.3012%
1.9184%
3.6579%
2.6347%
3.1572%
2.9485%
1.5253%
2.9976%
5.1366%
2.1734%
2.0506%
2.1051%
1.8804%
3.2136%
3.06%
2.1689%
3.3627%
2.0138%
1.4594%
2.3881%
6.0182%
2.9313%
1.8405%
1.6884%
1.1998%
3.4458%
15.2335%
4.0321%
4.0245%
7.8628%
4.8578%
7.0857%
8.3915%
13.756%
11.4884%
10.9699%
10.4519%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.